Correlation Between Hillstream Biopharma and Neoleukin Therapeutics
Can any of the company-specific risk be diversified away by investing in both Hillstream Biopharma and Neoleukin Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Hillstream Biopharma and Neoleukin Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Hillstream Biopharma and Neoleukin Therapeutics, you can compare the effects of market volatilities on Hillstream Biopharma and Neoleukin Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Hillstream Biopharma with a short position of Neoleukin Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Hillstream Biopharma and Neoleukin Therapeutics.
Diversification Opportunities for Hillstream Biopharma and Neoleukin Therapeutics
0.21 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Hillstream and Neoleukin is 0.21. Overlapping area represents the amount of risk that can be diversified away by holding Hillstream Biopharma and Neoleukin Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Neoleukin Therapeutics and Hillstream Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Hillstream Biopharma are associated (or correlated) with Neoleukin Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Neoleukin Therapeutics has no effect on the direction of Hillstream Biopharma i.e., Hillstream Biopharma and Neoleukin Therapeutics go up and down completely randomly.
Pair Corralation between Hillstream Biopharma and Neoleukin Therapeutics
Given the investment horizon of 90 days Hillstream Biopharma is expected to generate 2.47 times more return on investment than Neoleukin Therapeutics. However, Hillstream Biopharma is 2.47 times more volatile than Neoleukin Therapeutics. It trades about 0.05 of its potential returns per unit of risk. Neoleukin Therapeutics is currently generating about 0.07 per unit of risk. If you would invest 49.00 in Hillstream Biopharma on August 23, 2024 and sell it today you would lose (10.00) from holding Hillstream Biopharma or give up 20.41% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 99.38% |
| Values | Daily Returns |
Hillstream Biopharma vs. Neoleukin Therapeutics
Performance |
| Timeline |
| Hillstream Biopharma |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Neoleukin Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Hillstream Biopharma and Neoleukin Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Hillstream Biopharma and Neoleukin Therapeutics
The main advantage of trading using opposite Hillstream Biopharma and Neoleukin Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Hillstream Biopharma position performs unexpectedly, Neoleukin Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Neoleukin Therapeutics will offset losses from the drop in Neoleukin Therapeutics' long position.| Hillstream Biopharma vs. Virax Biolabs Group | Hillstream Biopharma vs. Revelation Biosciences | Hillstream Biopharma vs. Kiora Pharmaceuticals | Hillstream Biopharma vs. ZyVersa Therapeutics |
| Neoleukin Therapeutics vs. CytomX Therapeutics | Neoleukin Therapeutics vs. Spero Therapeutics | Neoleukin Therapeutics vs. Instil Bio | Neoleukin Therapeutics vs. NextCure |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Other Complementary Tools
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges |